Skip to main content
    R

    Repligen Corporation (RGEN)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $162.18
    -0.60 (-0.37%)

    Market Cap: $10.41B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Repligen Corporation (RGEN) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Repligen (RGEN) has a latest price of $162.18 on Nov 17, 2026, 18.4% below its 52-week high of $198.87. Its price rose 6.4% over the past 12 months. The month-end price rose 519.3% over the 10 years through Oct 2026, a compound annual rate of 20.0%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $290.50 in Oct 2021 and its lowest $28.57 in Oct 2016, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart RGEN with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RGEN.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 8.0%, and over 6 months it rose 49.4%. The month-end price rose 31.5% over the 3 years through Oct 2026, a compound annual rate of 9.6%.

    PeriodChange
    1 month-8.1%
    3 months-8.0%
    6 months+49.4%
    12 months+6.4%
    12 months, with dividends+6.4%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+31.5%+9.6%
    5 years-39.1%-9.4%
    10 years+519.3%+20.0%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 107.2%, and its weakest was 2022, when it fell 36.1%.

    YearCloseChange
    2026 through Oct 2026$176.94+8.0%
    2025$163.86+13.8%
    2024$143.94-19.9%
    2023$179.80+6.2%
    2022$169.31-36.1%
    2021$264.84+38.2%
    2020$191.63+107.2%
    2019$92.50+75.4%
    2018$52.74+45.4%
    2017$36.28+17.7%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 8.3% below its 50-day average of $176.92 and 11.5% above its 200-day average of $145.39.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$162.18
    52-week high$198.87-18.4%
    52-week low$100.99+60.6%
    50-day average$176.92-8.3%
    200-day average$145.39+11.5%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 50.6%.

    MeasureValue
    1-year beta1.21
    Largest fall, 1 year-40.3%
    Largest fall, 3 years-50.6%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    Repligen traded at 95.8x earnings at the end of 2025, against a 5-year median of 83.5x and a 10-year median of 82.6x.

    RGEN valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About RGEN

    What is RGEN's 1-year price change?

    Repligen's price rose 6.4% over the past 12 months. With dividends included, the 12-month total return was 6.4%.

    What is RGEN's 5-year price change?

    Repligen's month-end price fell 39.1% over the 5 years through Oct 2026, a compound annual decline of 9.4%. These figures leave out dividends.

    What is RGEN's 52-week high and low?

    Repligen's 52-week high is $198.87 and its 52-week low is $100.99. Its latest price of $162.18 on Nov 17, 2026 is 18.4% below the high.

    What is RGEN's beta?

    Repligen's 1-year beta against the S&P 500 is 1.21, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 40.3%.

    Is the RGEN chart free?

    Yes. Advanced Charting for RGEN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.